Rivaroxaban real world effectiveness in patients with atrial fibrillation (GUARDIAN)

18/12/2025
15/01/2026
EU PAS number:
EUPAS1000000869
Study
Finalised
Documents
Study protocol
Initial protocol
English (256.62 KB - PDF) View document
Study results
Study report
Abstract of study report
English (318.51 KB - PDF) View document
Other information